There are no direct drug interactions, but changes in diet, weight, or gastrointestinal symptoms may indirectly affect warfarin's anticoagulant effect
Commercial Insurance: Coverage, Copays, and Savings Card Details Tirzepatide is available as Zepbound, which is FDA approved for chronic weight management in adults with obesity or overweight plus a related condition like high blood pressure, type 2 diabetes, or high cholesterol
It is being developed by Eli Lilly and Company and is currently in Phase 3 clinical trials (registered on ClinicalTrials.gov)
If the site describes a "proprietary peptide matrix" or refuses to disclose the exact formulation, that is a red flag
[PMID: 10828840] PubMed record related to this compound for laboratory literature review